Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors

Clinical trial NCT02592083 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02592083
Sponsor: Thomas Hatschek
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early-Stage Breast Carcinoma Hormone Receptor Positive Tumor

Start date: 2015-10-01
Primary completion: 2019-02-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.